UP!

ALDR $18.88   View long term graphs

Alder Biopharmaceuticals is a pharmaceutical development company based in Bothell, Washington. Alder specializes in therapeutic monoclonal antibodies. The company was founded by Randall C. Schatzman, John A. Latham, and Mark J. Litton in 2004. The CEO is Dr. Randy Schatzman. Alder went public in May 2014.

Their best known drug is the monoclonal antibody eptinezumab, which is now in its second phase III trial for migraine prevention. They have a second monoclonal antibody drug for migraine, ALD-1910, currently in pre-clinical development. Alder licensed clazakizumab, previously ALD-518, an anti-IL-6 monoclonal antibody to Vitaeris, Inc. for worldwide marketing.

News

Alder BioPharmaceuticals, Inc. (healthcare)

Q reports

Period Date Adjusted Actuals EPS GAAP EPS
Q4 2019 2020-02-25 Future report Set alerts
Q3 2019 2019-11-07 Future report Set alerts
Q2 2019 2019-08-06 -0.72 -0.72
Q1 2019 2019-05-02 -1.63 -1.63
Q4 2018 2019-02-25 -1.19 -1.19
Q3 2018 2018-11-05 -0.91 -0.91
Q2 2018 2018-08-07 -1.04 -1.04
Q1 2018 2018-05-08 -1.73 -1.73
Q4 2017 2018-02-26 -0.80 -0.80
Q3 2017 2017-11-07 -0.92 -0.92

Ratings

2016-06-30 Reiterated Rating Jefferies Group Buy
2016-06-09 Reiterated Rating Jefferies Group Buy $61.00
2016-04-30 Reiterated Rating Brean Capital Buy
2016-04-21 Initiated Coverage Wells Fargo Outperform
2016-04-21 Initiated Coverage Wells Fargo & Co. Outperform
2016-04-20 Initiated Coverage Brean Capital Positive to Buy $45.00
2016-03-29 Reiterated Rating Jefferies Group Buy $62.00
2016-03-29 Reiterated Rating Credit Suisse Outperform $40.00
2016-03-29 Reiterated Rating Leerink Swann Outperform
2016-03-29 Reiterated Rating Credit Suisse Group AG Outperform $40.00
2016-02-15 Reiterated Rating Jefferies Buy $58.00
2016-02-15 Reiterated Rating Jefferies Group Buy $58.00
2016-02-13 Reiterated Rating Jefferies Group Buy
2016-02-01 Reiterated Rating Leerink Swann Buy
2015-10-15 Lower Price Target Jefferies Group Buy $58.00
2015-09-08 Initiated Coverage Jefferies Group Buy $72.00
2015-08-07 Reiterated Rating Leerink Swann Buy
2015-08-06 Boost Price Target Leerink Swann Outperform $62.00
2015-06-25 Reiterated Rating Credit Suisse Buy
2015-06-24 Initiated Coverage Credit Suisse Outperform $50.00
2015-05-05 Reiterated Rating Credit Suisse Outperform $36.00
2015-03-05 Boost Price Target Leerink Swann Outperform $24.00 to $31.00
2014-12-17 Boost Price Target Credit Suisse Outperform $19.00 to $34.00
2014-09-02 Lower Price Target Leerink Swann $26.00 to $24.00
2014-06-11 Initiated Coverage Sanford C. Bernstein Outperform $30.00
2014-06-02 Initiated Coverage Credit Suisse Outperform $20.00
2014-06-02 Initiated Coverage Wells Fargo & Co. Outperform
2014-06-02 Initiated Coverage Leerink Swann Outperform $26.00
2014-06-02 Initiated Coverage Wells Fargo Outperform
2016-06-30 Reiterated Rating Jefferies Group Buy
2016-06-09 Reiterated Rating Jefferies Group Buy $61.00
2016-04-30 Reiterated Rating Brean Capital Buy
2016-04-21 Initiated Coverage Wells Fargo Outperform
2016-04-21 Initiated Coverage Wells Fargo & Co. Outperform

There is presents forecasts of rating agencies and recommendations for investors about this ticker

Major Shareholders

Name Relationship Total Shares Holding stocks
Ventures West 8 Limited Partnership 11.26%  (3469528) ALDR /
Novo A/S SEE REMARKS 10.39%  (3201183) AKBA / ALDR / CRVS / FLXN / INGN / LPTN / OPHT / OTIC / RETA / RGDO / ZSPH /
PAKIANATHAN DEEPIKA 9.21%  (2838532) ALDR / ALXA / CALA / KPTI / OMED /
Delphi Management Partners VII, L.L.C. 9.21%  (2838532) ALDR /
TPG Group Holdings (SBS) Advisors, Inc. 8.08%  (2488533) AERI / ALDR / CDNA / CZR / EPRS / FSL / GPK / IMS / LPLA / MGNX / NCLH / NTI / OTIC / PKY / Q / ROKA / SABR / SCAI / SUP / TIPT / TMHC / TNDM / VCYT / ZMH /
Davidson Aaron 1.68%  (516395) ALDR / OCRX /
H.I.G. Venture Partners II, L.P. 1.68%  (516395) ALDR /
DOW STEPHEN M 1.00%  (307190) ALDR / CTXS / CYTK /
Latham John A Chief Scientific Officer 0.79%  (243208) ALDR /
Schatzman Randall C President and CEO 0.47%  (145172) ALDR /
Litton Mark James Chief Business Officer 0.38%  (116451) ALDR /
SIEGALL CLAY B 0.10%  (31714) ALDR / SGEN /
Benedict Larry Sr. VP Finance 0.10%  (30989) ALDR /
Montgomery Alan Bruce 0.03%  (9628) ALDR / XNCR /
YARNO WENDY L 0.02%  (5000) ALDR / DRTX / INO / MDVN / PETX / STJ /
JAGGERS JOHN V 0.01%  (4458) ALDR / CPST /
Bucher James B Sr. VP & General Counsel 0.01%  (1623) ALDR /

Comments